New Zealand markets open in 2 hours 46 minutes

Hoth Therapeutics, Inc. (HOTH)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.1800-0.0100 (-0.84%)
At close: 04:00PM EDT
1.2000 +0.02 (+1.69%)
After hours: 06:45PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.1900
Bid0.8424 x 200
Ask1.5300 x 200
Day's range1.1700 - 1.2000
52-week range0.9900 - 4.3000
Avg. volume439,546
Market cap5.769M
Beta (5Y monthly)0.65
PE ratio (TTM)N/A
EPS (TTM)-2.3000
Earnings date09 Aug 2024 - 13 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est4.67
  • PR Newswire

    Hoth Therapeutics to Attend EF Hutton Annual Global Conference, May 15, 2024

    Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that Robb Knie, Chief Executive Officer, is scheduled to attend the EF Hutton Annual Global Conference in New York, NY.

  • PR Newswire

    Hoth Therapeutics Announces Exercise of Warrants for $4.2 Million Gross Proceeds

    Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient focused biopharmaceutical company, today announced the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 2,500,000 shares of common stock of the Company originally issued in January 2023, having an exercise price of $5.00 per share, at a reduced exercise price of $1.6775 per share. The shares of common stock issuable upon exercise of the warrants are registered pursuant

  • PR Newswire

    Hoth Therapeutics' Wholly Owned Subsidiary, Advances AI-Driven Discovery for Obesity Treatment

    Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient focused biopharmaceutical company, is excited to announce a significant breakthrough by its subsidiary,, in the field of obesity treatment. Utilizing advanced artificial intelligence, has identified a promising new therapeutic candidate, culminating in a strategic patent filing.